Literature DB >> 7240977

Metabolic heterogeneity of apolipoprotein B in the rat.

C E Sparks, J B Marsh.   

Abstract

Triglyceride-rich lipoprotein apoprotein catabolism was studied in rats from 5 to 60 min after intravenous injection of 125I-labeled lipoproteins. The plasma and liver labeled apoprotein content was analyzed by gel filtration column chromatography using an elution buffer containing 1% sodium dodecyl sulfate. The method resolved two B apoproteins of lower (apo B1) and higher (apo Bh) molecular weight. Total apoprotein B disappeared from plasma faster than either apo E or apo C and the smaller sized apo B1 had the most rapid disappearance, with 90% being lost after 60 min. The larger sized apo Bh disappeared rapidly from the plasma in the first 15 min but between 15 and 60 min 40% of the apo Bh remained in the plasma, associated with low density lipoprotein. Apoprotein analysis of liver homogenates was consistent with the plasma results. There was 28% of apo B1 compared to 16% of apo Bh present in the liver 5 min after injection, expressed as percent of initial injected radioactivity in each fraction. Apo B1 and apo Bh were the predominant liver apoproteins up to 30 min but by 60 min there was little of either apo B in the liver. In contrast to apo B, there was a relatively constant amount of apo E and apo C, about 10%, associated with the liver over 60 min. Plasma apo E declined progressively to 68% and apo C to 86% of initial concentration by 60 min. These findings suggest that there is differential hepatic catabolism of a subpopulation of triglyceride-rich lipoproteins containing apo B1. A population of triglyceride-rich lipoproteins containing apo Bh preferentially enters the low density lipoprotein pool with a slower catabolism. The results are consistent with an hypothesis that apo B1 mediates binding and rapid hepatic catabolism of its associated lipoproteins. Metabolic heterogeneity of the triglyceride-rich lipoproteins may be explained by the molecular heterogeneity of apoprotein B.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240977

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

1.  Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine.

Authors:  G E Tennyson; C A Sabatos; K Higuchi; N Meglin; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B.

Authors:  T S Watt; R M Watt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  Kinetic analysis of plasma VLDL-TG and VLDL-remnant-TG turnover in anesthetized rats.

Authors:  R Bickerstaffe; I Lyon; H Rostami; N Baker; J Elovson
Journal:  Lipids       Date:  1983-08       Impact factor: 1.880

4.  Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes.

Authors:  J D Sparks; C E Sparks; L L Miller
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

5.  Studies on the production of low density lipoproteins by perfused livers from nonhuman primates. Effect of dietary cholesterol.

Authors:  F L Johnson; R W St Clair; L L Rudel
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  The apoprotein B-independent hepatic uptake of chylomicron remnants.

Authors:  J Borensztajn; G S Getz; R J Padley; T J Kotlar
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

7.  Human apolipoprotein B: identification of cDNA clones and characterization of mRNA.

Authors:  M Mehrabian; V N Schumaker; G C Fareed; R West; D F Johnson; T Kirchgessner; H C Lin; X B Wang; Y H Ma; E Mendiaz
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

8.  Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats.

Authors:  J D Sparks; R Zolfaghari; C E Sparks; H C Smith; E A Fisher
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

9.  Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins.

Authors:  A J Lusis; R West; M Mehrabian; M A Reuben; R C LeBoeuf; J S Kaptein; D F Johnson; V N Schumaker; M P Yuhasz; M C Schotz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  Catabolism of very low density lipoproteins in experimental nephrosis.

Authors:  D W Garber; B A Gottlieb; J B Marsh; C E Sparks
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.